SERENGEN will be exhibiting at the BIO Europe at the BIO.NRW booth (#45). We are looking forward to meeting investors who seek a technology platform that is set to revolutionize early drug discovery. We are also keen to talk to potential customers who place quality above numbers game. Finally, we would like to explore strategic partnerships during Serengen's start-up phase and beyond.
